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Abstract: Sequential liver and kidney transplantation from the same 
donor was performed in 2 patients. The kidney in Patient 1, which was 
transplanted after the liver, was hyperacutely rejected and removed 6 
hours later. The first liver as well as another liver transplanted 3 days later 
developed widespread hemorrhagic necrosis. Although the cytotoxic 
crossmatch of preoperative recipient serum with both donors was nega-
tive, patchy widespread IgM and C q deposits were found in all 3 organs. 
In Patient 2, who had a strongly positive cytotoxic crossmatch with his 
donor, the liver suffered a massive but reversible injury, while the kidney 
never functioned. Both patients developed a coagulopathy a few minutes 
after liver revascularization. The kidneys in these cases had served like 
the canaries which miners once used to detect a hostile environment and 
their presence made more understandable how an indolent version of 
hyperacute rejection of the liver can take place. 
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The almost immediate losses of kidneys transplant-
ed across blood group (ABO) barriers into reci-
pients with antigraft isoagglutinins were the first 
examples of humorally-mediated hyperacute rejec-
tion (1). Soon after, the prompt destruction of a 
kidney transplant in a patient whose serum con-
tained cytotoxic antigraft antibodies was described 
by Terasaki et al. (2) and called hyperacute rejec-
tion by Kissmeyer-Nielsen et al. (3). Rejection of 
the human heart within a few minutes to a few 
hours also has been reported (4, 5, 6). However, 
there have been no unequivocal examples of hyper-
acute rejection after clinical hepatic transplan-
tation, supporting the widely held opinion (7-11) 
that the liver is resistant to this kind of antibody-
mediated injury. 
We present evidence, from 2 cases of combined 
liver and kidney transplantation, that humoral re-
jection of human liver grafts, analogous to hyper-
acute renal rejection, can occur. However, the pro-
cess develops more slowly than with the kidney -
and presumably other organs - it may be reversible, 
and in individual cases it may be impossible to 
establish a direct relation to antigraft antibodies. 
It will be suggested also that a progressive and 
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severe coagulopathy developing shortly after 
hepatic revascularization should arouse suspicion 
of an acute antibody reaction even if there has not 
been a positive cytotoxic antibody crossmatch with 
the donor. 
Case reports 
Case 1 
A 61-yr-old male with a 30-yr history of ulcerative 
colitis had an 8-yr history of progressive jaundice, 
right upper quadrant pain, and fever. The diagnosis 
of sclerosing cholangitis was proved by cholangiog-
raphy and biopsy. The physical examination was 
unremarkable except for deep jaundice, hepatome-
galy and splenomegaly. 
At admission, liver function tests included: total 
bilirubin 15 mg/- 100 ml (257 mmol/I), alkaline 
phosphatase 679 V/I (normal < 100), aspartate am-
inotransferase (AST) 65 V/I (normal < 34) and 
prothrombin time 15 seconds/ll s control. Indo-
cyanine green retention was 77% at 20 min (normal 
< 5%). Hepatitis B serology was negative. Doppler 
study of the liver vessels showed no hepatopetaI 
flow through the portal vein which was patent. 
During 4 wk hospitalization, the serum bilirubin 
rose to 27.1 mg/- 100 ml (465 mmol/I), other liver 
chemistries deteriorated, and the patient became 
anuric. On 18 and 19 December 1986, orthotopic 
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liver transplantation was performed from a 27-yr-
old donor of the same blood type (AIRh +) as 
the recipient. There were no major complications 
during the hepatectomy and during performance 
of the vena caval and portal vein anastomoses. 
When the liver allograft was revascularized with 
portal blood after a cold ischemia period of 5-1/2 
h, it perfused well and produced bile immediately. 
The recipient hepatic artery had an intimal dis-
section, and arterialization could not be completed 
for another 6-1/2 h. Eventually, a free graft of 
donor iliac artery was anastomosed to the infrare-
nal aorta of the recipient, tunneled beneath the 
pancreas, and anastomosed to the graft coeliac 
axis (Table 1). Immunosuppression in the operating 
room consisted of 1 g intravenous methylpredniso-
lone before revascularization and 2 mg/kg of intra-
venous cyclosporine which was given as soon as 
the portal revascularization was completed. 
By the time biliary tract reconstruction was 
started at noon on December 19, 1986 (Table I), 
the initially copious bile production had ceased 
although the gross appearance of the liver was not 
obviously abnormal. The biliary tract reconstruc-
tion was with a choledochojejunostomy. 
The operation did not start out being technically 
difficult. During the initial phases including hepa-
tectomy, the wound was dry with good clot forma-
tion. By the time of portal revascularization, cumu-
lative blood loss was 3 1. Diffuse hemorrhage then 
ensued, necessitating replacement with 20 units of 
red blood cells and 20 units of fresh frozen plasma 
over the next 5 h. By the end of the operation, 
blood loss was an estimated 371. Total replacement 
was with 50 units packed red blood cells, 50 units 
fresh frozen plasma, 38 units of platelets, and 30 
units cryoprecipitate. 
Observations on blood coagulation were made 
throughout. Preoperatively, the coagulation profile 
was not alarming in comparison to that of most 
liver transplant recipients (12). The prothrombin 
time was 1.3 times control; activated partial throm-
boplastin time, thrombin time, and reptilase time 
were 2 times control; the fibrinogen level was 420 
mg%; factor II was 0.47 U/ml; factor VIII was 
2.75 U/ml; euglobulin lysis time was> 2 h; fibrin 
degradation products were> 40 Ilg/ml, and platelet 
count was 195000/mm3• Thrombelastography 
(TEG) showed a minimal prolongation of reaction 
time suggesting deficiency of coagulation factors. 
This TEG profile was maintained until reperfusion 
of the liver graft, except that fibrin degradation 
products became positive and euglobulin lysis time 
fell to less than 60 min during the anhepatic stage 
while the patient was on veno-venous bypass (13). 
Beginning abruptly 30 min after portal reper-
fusion, the TEG showed signs of inhibition of co-
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agulation, with severely prolonged reaction time 
and formation of poor quality clots. The prothrom-
bin time rose from 12.8 to 18 s and the platelet 
count was 150000/mm3• Response to treatment 
with cryoprecipitates and platelets was minimal 
and transient. Fibrin monomers and fibrin de-
gradation products were negative and euglobulin 
lysis time was normal. Fibrinolysis was seen on 
TEG on only one occasion and was not treated. 
After the upper abdominal incision had been 
closed, a kidney from the same donor was trans-
planted without difficulty to the left: pelvic extra-
peritoneal location (Table 1). The renal graft per-
fused normally at first, but it did not make urine 
and, within 15 min, it became cyanotic. Cortical 
and ureteric bleeding ceased. The renal circulation 
was only temporarily improved with intraarterial 
or periarterial papaverine or xylocaine, or by intra-
venous prostaglandin E. The hyper acutely rejected 
kidney was removed 6 h after it had been 
revascularized (Table 1). The renal vascular anas-
tomoses were perfect and the vessels did not con-
tain clots. 
Postoperatively, the hepatic failure became 
worse with progressive elevations of serum AST, 
bilirubin, and prothrombin time. OKT3 therapy 
was added to cyclosporine and steroids at the end 
of the 1st postoperative day. It was obvious that a 
catastrophic hepatic injury had occurred. 
A second liver was obtained from a 21-yr-old 
physiologically stable donor of Al Rh + blood type. 
At reoperation, the excised first liver graft: which 
had been in place for 72 h was swollen and hard 
with areas of gross hemorrhagic necrosis. The sec-
ond liver was revascularized with both portal ve-
nous and hepatic arterial flow after a cold ischemia 
time of 4-1/2 h. Initial perfusion again was good 
with prompt bile production, but the bile flow had 
already stopped by the time the biliary tract recon-
struction was performed and a biopsy was obtained 
several hours later. Hepatic failure was unrelieved 
and the patient died 1-1/2 d later. Permission for 
autopsy was denied. 
Case 2 
A 12-1/4-yr-old male with cystinosis had slowly 
evolving end stage renal disease and at the age of 
6 yr was placed on an experimental protocol, using 
cysteamine. Hepatic veno-occlusive disease de-
veloped with portal hypertension, splenomegaly, 
and pancytopenia. The patient had massive hem-
orrhages from esophogeal varices in May, 1982, 
and was submitted to a gastric devascularization 
procedure. Cysteamine treatment was stopped, but 
his liver failure became worse including ascites. 
Renal failure also was progressive and in January, 
The case of the canary kidneys 
Table 1. Relation in case 1 of organ revascularization times to tissue collection and histopathologic findings 
Date and Time 
12/19/86-2:30 am 
12/19/86-9 am 
Event 
liver graft 1 portal 
vein opened 
liver graft 1 artery 
opened 
Comments 
Perfused well, prompt bile pro-
duction, wound dry for 30 min-
utes, then diffuse hemorrhage 
Liver grossly normal, wound 
now dry but bile prod uction 
ceased 
12/19/86-11 :30 am liver graft 1 biopsy after 9 hrs perfusion 
12/19/86-7:30 pm kidney graft revascu- well perlused for a few minutes, 
larized then cyanotic 
Liver Kidney 
Sinusoidal congestion with neutrophil -
clustering and fibrin deposition. Diffuse 
spotty acidophilic necrosis of hepato-
cy1es and microvesicular steatosis. 
Slight neutrophil sludging in portal 
capillaries. Immune stains; light IgM 
and C" in arterial and portal vein 
walls. 
12/19/86-1 0 pm kidney graft biopsie gross diagnosis hyperacute re- -
jection 2.5 hrs after revascul-
arization 
Glomerular congestion with occasional 
neutrophil sludging and focal capillary 
loop thrombosis. Platelet-fibrin 
thrombi in two arteries. Prominent 
tubular vacuolization and interstitial 
congestion. IgM and C,q in arterial 
walls; same pattern as in liver. 
12/20/86-1 :30 am kidney graft removal Vessels open no technical prob- - Qualitatively same as biopsy findings; 
approximately 10-20% of glomeruli in-
volved. Focal subintimal fibrinoid ne-
crosis of arterioles, interlobular arteries 
and veins. IgM + C,q arteries and ar-
terioles 
12/22/86-2 am 
12/22/86-2 am 
12/22/86-4:25 am 
12/22/86-10 am 
12/24/86-10 pm 
liver graft 1 re-
moval 
back table biopsy 
liver graft 2 
liver graft 2 portal 
vein opened 
lems after 6 hours revascul-
arization 
Large, mottled, geographic 
hemorrhage necrosis 72 hours 
after revascu larization 
2nd graft grossly normal, per-
fect donor 
perfused well, made bile im-
mediately; arterialized 30 min-
utes later 
liver graft 2 biopsy No distinctive gross features, 
5.5 hrs after reperfusion 
died - hepatic fail-
ure; no autopsy 
1986, his blood urea nitrogen (BUN) and creatinine 
(Cr) were 53 mg/100 ml (18.9 mmol/l) and 5.4 mg/ 
100 ml (477.3 mmol/l) respectively. 
On March 3, 1986, the patient underwent ortho-
topic liver transplantation and renal transplan-
tation in that order from the same donor. On ad-
mission, the recipient was stunted with a weight 
(21 kg) and height below the fifth percentile. He 
had gross ascites and a healed transverse wound 
Enlarged graft (1700 gm) Focal ar-
terial necrosis and slight fibrin depo-
sition in sinusoids. Multiple infarcts 
and candida superinfection in hilum. 
Patchy IgM and C,q in arteries. 
Normal histologic appearance 
Striking change when compared to 
preimplantation sample. Findings de-
scriptively similar to those seen in 
first graft, but quantitatively worse 
of the upper abdomen. Liver chemistries included 
bilirubin 0.8 mg/100 ml (15.3 mmol/l); prothrom-
bin time 15 s; albumin 2.4 gil 00 m\. AST was 
mildly increased. Platelet count was 67000/mm3. 
The donor, a 6-yr-old child of the same weight as 
the recipient, was at another hospital in Pittsburgh. 
The donor was stable throughout the procurement 
operation. Preservation as with Case 1 was with the 
"slush" technique after infusion with cold Euro-
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Collins solution in situ (14). The portal circulation 
was restored to the transplanted liver after a cold 
ischemic period of 3-1/2 h including 45 min after 
removal from the slush solution; arterialization was 
completed 30 min after this. Veno-venous by-pass 
was used during the anhepatic phase. Intraopera-
tive immunosuppression was with 250 mg intra-
venous prednisolone and 40 mg cyclosporine. 
A small amount of bile was produced immedi-
ately after revascularization but this ceased within 
a few minutes. The operation had been made diffi-
cult up to this point by the presence of massive 
adhesions from the emergency operation of 1982. 
After reperfusion of the graft, the problem of he-
mostasis was compounded by a coagulopathy. Pro-
thrombin time and partial thromboplastin times 
ranged between 1.5 and 2 times control and the 
platelet count was 30000 and 50000/mm3 in spite 
of adequate replacement with fresh frozen plasma 
and platelets. The child received 43 units of red 
cells, 34 units of fresh frozen plasma, and 36 units 
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Fig. 1. Course of a highly sensitized child who had a liver 
transplantation despite a positive cytotoxic crossmateh, with 
very severe but reversible hepatic injury. A kidney transplanted 
from the same donor after the liver was in place, and while the 
crossmatch remained strongly positive, never functioned. 
40 
of platelets. Completion of the liver transplantation 
required 21 h, of which most was spent controlling 
diffuse hemorrhage. 
After the upper abdominal incision was closed, 
a kidney from the same donor was transplanted 
without technical difficulty to the right pelvic extra-
peritoneal site. Renal revascularization was com-
pleted 18 h after revascularization of the liver and 
with a cold ischemic period of 22 h (Table 2). The 
kidney was well perfused at first, but promptly 
became soft and cyanotic as if hyperacute rejection 
had begun. Because the cyanosis and poor per-
fusion could be reversed with the intra-arterial in-
jection of papaverine and xylocaine, the renal graft 
was left in place. However, it never functioned. The 
homograft renal vessels were shown with ultra-
sound to be patent. Radionuclide scans showed 
extremely poor flow. Hemodialysis was begun 3 
times/wk. 
The liver also sustained a grave acute injury with 
serious perturbations of all of the liver functions 
(Fig. 1) which persisted for more than 2 wk. The 
child required ventilatory support for 60 d, and 
was in the intensive care unit for 62 d with wound 
infections and dehiscence, ileus from antacid in-
spissation, and other complications in addition to 
renal and hepatic failure. Eventually the liver re-
covered (Fig. 1). 
On 4 April 1987, 11 months after the combined 
liver-kidney transplantation, a second kidney 
transplantation was performed with a good result. 
The patient remains well with normal hepatic and 
renal function. 
Tissue typing and serologic correlations 
Patient 1 was matched with the first donor at one 
HLA antigen at the A locus. With the second do-
nor, there was one A one DR locus match. The 
recipient's serum was cytotoxic to less than 20% 
of the first donor's lymphocytes; this was interpret-
ed to be a negative crossmatch. No cytotoxicity 
was detected when the crossmatch was rechecked 
with a fresh serum sample after the first liver had 
been transplanted and just before the kidney was 
revascularized and hyperacutely rejected. There 
was also a negative crossmatch with the second 
donor. 
Patient 2 was poorly matched with his liver-
kidney donor with only one A locus antigen iden-
tity. On the day of the double organ transplan-
tation, he had a panel reactive antibody (PRA) of 
91 % and a complete kill cytotoxic crossmatch with 
the donor at a 1: 16 titer. By absorption with pooled 
platelets, the PRA fell to 4%, indicating anti-HLA 
specificity of the antibodies. 
The positive crossmatch persisted after the liver 
Table 2. Tissue collections in case 2 
Date and Time Event Comment 
3/3/86-7:15 pm liver graft, portal vein perfused well 
opened 
3/3/86-7:45 pm liver graft artery 
opened 
liver grossly normal, but little 
bile production 
The case of the canary kidneys 
Liver Kidney 
3/4/86-1 :45 pm kidney graft revascu- kidney turned cyanotic and soft -
larized 
3/18/86 exploration for intes- Had severe hepatic pulmonary, 
tinal obstruction; and renal failure 
hepatic and renal bi-
opsy 
4/22/86 renal biopsy done 7 weeks postop 
because of non-func-
tion 
'Prominent cholangiolitis with central 
ballooning and cholestasis with bile 
plugging of cholangioles. Prominent 
portal neutrophilic exudate. No evi-
dence of cellular rejection. No immu-
noglobulins detected 
Occasional glomerular neutrophils in 
capillary loops. Endothelial swelling 
with one arteriolar thrombus. Promi-
nent isometric vacuolization of tubules 
with cysteine crystal deposition. Focal 
congestion and occasional neutrophils 
in peritubular capillaries. No immuno-
globulins detected 
Small shrunken glomeruli with focal 
capillary loop thickening and mesangial 
widening. Mild arteriolar thickening 
and arterial medial hypertrophy. Promi-
nent interstitial fibrosis and moderate 
mixed inflammatory infiltrate with focal 
tubular damage and cysteine depo-
sition. No immunoglobulins detected 
'Other liver biopsies on March 18, 21, 25 and 28 and on April 4 were essentially the same but with slow improvement. 
transplantation without the antibody clearing by 
hepatic grafts described by Fung et al. (15). The 
crossmatch was still strongly positive using serum 
collected after 10, 15, and 25 d. After many 
months, the PRA diminished to 2%. The kidney 
successfully transplanted II months after the 
double organ transplantation was from a donor 
with whom the patient had a negative crossmatch. 
Histopathologic studies 
Biopsies or other tissue samples were obtained 
from livers or kidneys at the time intervals after 
Fig. 2. Biopsy of the normal second liver homograft before 
revascularization in Patient 1 (H & E, 125 x). 
their vascularization summarized in Tables I and 
2. The tissues were fixed in neutral buffered forma-
lin or frozen in OCT compound for immunofluore-
scence. The sections were stained with hematoxylin 
and eosin. Kidney sections were also stained with 
periodic acid-Schiff, J one's silver stain and tri-
chrome. Immunofluorescence and immunoperox-
idase staining for IgG, IgM, IgA, Clq, C3, C4 and 
fibrinogen were performed using a direct technique 
on frozen tissue or indirect on paraffin embedded 
tissue (16). Electron microscopy was carried out 
on the kidney transplant removed from the first 
patient. This confinued that there were no platelet 
aggregates and very few granulocytes in the vessels; 
there was patchy sludging of red cells. 
Case 1 
Both liver grafts in this patient suffered a devastat-
ing injury within a few hours after revasculariza-
tion (Table I). Before transplantation, both grafts 
were thought to be normal, and this was proved in 
the second graft by preperfusion biopsy (Fig. 2). 
The post-perfusion biopsies of both liver grafts had 
the ominous findings summarized in Table 2 (Fig. 
3). In addition, the early biopsies of both livers had 
a light patchy but widespread deposition of IgM 
and Clq in the portal veins and hepatic arteries. 
These findings were still present in the first liver 
graft at 3 d (Fig. 4B). By this time, when the first 
liver graft was removed, the early morphologic 
41 
Starzl et al. 
Fig. 3. Same liver graft as in Figure 2, 5 hours after rcvascu-
larization. The massive but subtle injury pattern is summarized 
in Table I (H & E, 125 x ). 
changes had progressed to sub-massive necrosis 
(Fig.4A). 
The kidney transplanted to this patient 17 h after 
revascularization of the first liver graft had focal 
fibrinoid changes of the subintimal media of the 
interlobular arteries and afferent arterioles (Fig. 
SA); the other findings are summarized in Table 1. 
The immunoglobulin deposits in the kidney were 
qualitatively similar to those in both livers (Fig. 
5B). 
Case 2 
There was serious damage to the liver by the time 
the first biopsy was obtained 15 d postoperatively 
(Table 2). The findings in the kidney graft at this 
time and later are summarized in Table 2. 
Discussion 
Breaches of ABO compatibility in kidney trans-
plantation have provided the most analyzable 
prototypes of hyperacute rejection since the specif-
icities of the antigraft antibodies (the isoaggluti-
nins) have been so obvious (1, 6) . The same can be 
said for hearts (6). With livers, Demetris et al. 
(J 7) have demonstrated inconstant isoagglutinin 
fixation in the microvasculature of AB incompat-
ible liver grafts in a collection of cases in which 
hemorrhagic infarction occurred five times more 
frequently than with ABO compatible grafts. Al-
though the process was slower than with hyper-
acute rejection of kidneys, the end result was the 
same. 
After it was realized that cytotoxic anti-lympho-
cyte antibodies in kidney recipients caused the 
same syndrome of hyperacute rejection as ABO 
incompatibility (2, 3), the "warm" IgG anti-T-
lymphocyte variety of antibody was accepted in-
creasingly as the responsible lymphocytotoxin (18). 
It has proved to be an oversimplification to view 
these anti-HLA antibodies as the only cause of 
hyperacute rejection in ABO compatible renal reci-
pients since other antibodies have been implicated 
including the IgM variety (6, 19) or those attacking 
vascular endothelium (5). It has long been recog-
nized (20) and recently confirmed (19) that hyper-
acute rejection can occur without detectable sero-
logic evidence of preformed antibodies and with 
little evidence immunoglobulin deposition in the 
ruined kidney graft (20). 
Whether or not the initiating antigen-antibody 
reaction is demonstrable with conventional sero-
logic techniques, the central event of hyperacute 
rejection of the kidney has been thought to be 
-Fig. 4. A. First failed liver allograft of Patient I. The liver contained large areas of necrosis (arrow) 3 days after revascularization 
PT = portal tract ; (H & E, 125 x). B. Focal deposition of JgM (arrow) in a portal tract artery (immunoperoxidase for IgM, 450 x ). 
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Fig. 5. Kidney which was hyperacutely rejected in Patient I and removed after 6 hours. A. Fibrinoid necrosis (arrows) of interlobular 
artery which is crammed with red cells (H & E, 225 x). B. Deposition of IgM in polar arteriole (arrow). A glomerulus occupies 
the left half of the field and has irregular staining in the capillary loops and mesangium (immunoperoxidase) for IgM, 450 x ). 
occlusion of the graft microvasculature by rapidly 
sequestered formed blood elements including plate-
lets as well as by clotting factors (20-22). Polymor-
phonuclear leukocytes infiltrate the stricken tissues 
contemporaneously or slightly later (23). The role 
of non-specific mediators of the inflammatory cas-
cade in this seemingly irreversible pathogenesis has 
long been suspected (20, 24). Recently, Ito et al. 
(25) have correlated hyperacute renal rejection in 
sensitized rabbits with the appearance of the 
powerful inflammatory mediator, platelet activa-
ting factor (PAF). The antibody-initiated cascade 
in heterografts or homo grafts can be ameliorated 
with a PAF inhibitor (26, 27). 
With hyperacute renal rejection, the plugging of 
the microvasculature with formed blood elements 
and clotting factors occurs so quickly after an im-
mune event that this has been considered to be the 
primary pathophysiology (20, 24). Treatment with 
chelating agents (28) and cobra venom (29) which 
prevent complement activation can delay the pro-
cess, but the absence of neutrophils (30) and plate-
lets (31) cannot. 
However, observations in the transplanted kid-
neys of our 2 patients did not appear "classic" for 
untreated hyperacute rejection. This suggests that 
a period of intense immunologically-mediated va-
soconstriction could precede the mechanical clo-
sure of the microvasculature. If this vasoconstric-
tion is not relieved spontaneously or with drugs, 
the kidney may be lost immediately even though 
most of the vascular bed is still morphologically 
intact as was the case in patient I . Evidence in 
animal models that immunologically-mediated va-
soconstriction is a primary event in accelerated or 
hyperacute rejection has been reported frequently 
(25, 32- 34). 
Whatever the primary events, a striking sub-
sequent feature of hyperacute renal rejection can 
be the development of a consumption coagulopa-
thy, and sometimes fibrinolysis (21, 22, 24, 35). If 
renal blood flow falls to zero, the exclusion of the 
kidney graft from the circulation eliminates the 
problem, but if renal blood flow is maintained by 
an equilibrium of clotting and fibrinolytic process-
es coagulopathy may develop, necessitating graft 
nephrectomy (24). 
Hyperacute rejection of the liver has been looked 
for ever since recognition of the complication in 
kidney grafts. Twenty years ago, Drs. G. M. Willi-
ams and David Hume attributed the hemorrhagic 
necrosis of an orthotopic liver graft a few hours 
postoperatively to humoral rejection (36). Lym-
phocytotoxic antibodies could not be detected in 
the recipient's serum and significant immunoglobu-
lin deposits could not be found in the graft with 
immunofluorescence studies. However, serum col-
lected preoperatively from the recipient as well as 
eluates of the liver graft at autopsy lysed cultured 
renal cells of the original donor. 
The gross description of the liver in H ume's child 
(36) was remarkably similar to the findings many 
years later of Knechtle et al. (37) in rats sensitized 
with skin grafts before orthotopic liver transplan-
tation. The liver grafts in these rat experiments 
were provided only with a portal blood supply. 
Gubernatis et al. (38) demonstrated accelerated re-
jection of the fully vascularized liver in Rhesus 
monkeys similarly sensitized with skin grafts. 
Hepatic failure and complex clotting disorders in 
the sensitized monkeys reduced the survival from 
an expected mean of 26 d to 2.5 d. 
Although these observations have made it clear 
that liver grafts can be abruptly rejected, clinical 
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evidence accrued over the last 15 yr suggests that 
the liver is more resistant to humoral antibody 
attack than other organs (7-10). Animal experi-
ments have demonstrated the difficulty of inducing 
intense enough sensitization to reduce hepatic graft 
survival (39, 40) or have shown that liver heterog-
rafts are rejected by heterospecific antibodies later 
and less violently than the heart and presumably 
other organs (41, 42). The fact that no one has 
reported the rejection of a liver on the operating 
table suggests that humoral rejection of the human 
liver, if it occurs at all, does so at a slower pace 
than with kidneys, which can be destroyed within a 
few minutes. The non-existent correlation between 
cytotoxic crossmatches, immunoglobulin fixation 
in the hepatic graft, and the outcome after clinical 
liver transplantation (10) has made it impossible to 
state unequivocally that any human liver has ever 
undergone hyperacute rejection. 
Observations in our 2 cases have clarified the 
situation. Miners in the past took canaries with 
them to work in order to provide a warning: if the 
birds collapsed there were toxic fumes in the mine. 
The kidneys were the 'canaries' in our 2 liver-kid-
ney recipients. Their immediate destruction or pri-
mary non-function identified an intensely hostile 
immune environment which, in Case 1, explained 
the loss of two consecutive livers. This kind of 
prompt destruction of hepatic retransplants in pa-
tients whose first liver grafts have been lost for 
inadequately explained reasons has been seen by 
us on a number of occasions as well as in other 
centers, causing the word-of-mouth descriptive 
term "liver eaters" to be applied to such recipients. 
In our Patient 2, the hepatic insult was grave but 
reversible, whereas the kidney never functioned. 
It remains to be explained why the liver is less 
susceptible to hyperacute rejection than the kidney. 
If vasoconstriction is a primary or important ele-
ment of hyperacute rejection, the resistance of the 
liver to its deadly effects could be explained by the 
double hepatic blood supply with its less vasoreac-
tive portal venous system. The coagulopathy seen 
in both of our recipients may be characteristic of 
the injury pattern of this kind of liver rejection, 
and should trigger suspicion of this diagnosis. 
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